Rebecsinib Clinical Trial Means New Options for Blood Cancer
A clinical trial of rebecsinib — an investigational drug that inhibits the ADAR1 gene involved in the growth of more than 20 cancers — is underway at UC San Diego.
Health & Behavior
The Latest
Nobel Laureate and UC San Diego Alumnus Susumu Tonegawa (1939-2026)
Susumu Tonegawa, who made key contributions to immunology and neurobiology and became UC San Diego’s first alumnus to receive a Nobel Prize, passed away on July 11. His research resolved a long-standing puzzle about how the immune system generates millions of antibodies from a small set of genes.
Mindfulness-Based Therapy for Opioid Misuse Offers Massive Return on Investment
A mindfulness-based treatment for opioid use disorder could generate $12 in economic benefit for every dollar spent, a massive improvement on current approaches.
One Month on a Vegan Diet Shifts Epigenetic Patterns Associated with Aging and Inflammation
Researchers from University of California San Diego have found that switching to a vegan diet for just one month can alter the body’s epigenetic landscape in ways associated with reduced inflammation and biological aging.
UC San Diego Researchers Use SDSC’s Expanse to Better Understand Bone-Like Minerals
Hydroxyapatite is already widely used in medical materials to help strengthen teeth and bones, since it is the primary mineral naturally found in bone. Researchers introduced europium’s light-emitting properties to make the material easier to see in bioimaging applications.
From Code to Care: How UC San Diego Is Leading the Way in AI for Health Care
At the U.S. News & World Report Healthcare of Tomorrow conference, leaders from UC San Diego and from across the health care industry gathered in Washington, D.C., to explore a defining question: How can artificial intelligence improve health care while keeping patients at the center?
Stay in the Know
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
